Factors Associated with the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study
Open Access
- 1 July 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (1) , 111-119
- https://doi.org/10.1086/518619
Abstract
Background. Human immunodeficiency virus (HIV)–infected persons may be at increased risk for developing type 2 diabetes mellitus because of viral coiKeywords
This publication has 33 references indexed in Scilit:
- Higher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus TenofovirAIDS Research and Human Retroviruses, 2006
- Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort StudyAIDS, 2005
- Antiretroviral Therapy and the Prevalence and Incidence of Diabetes Mellitus in the Multicenter AIDS Cohort StudyArchives of internal medicine (1960), 2005
- Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individualsAIDS, 2003
- Protease Inhibitor Use and the Incidence of Diabetes Mellitus in a Large Cohort of HIV-Infected WomenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Abacavir and DiabetesNew England Journal of Medicine, 2001
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudineAIDS, 1998